Fasting-mimicking diet remodels gut microbiota and suppresses colorectal cancer progression

Man Luo,Qingyi Wang,Yong Sun,Yao Jiang,Qiwen Wang,Yanrou Gu,Zhefang Hu,Qianyi Chen,Jilei Xu,Shujie Chen,Tongyao Hou,Lijun Feng
DOI: https://doi.org/10.1038/s41522-024-00520-w
IF: 9.2
2024-06-26
npj Biofilms and Microbiomes
Abstract:The progression of colorectal cancer is closely associated with diet. Fasting-mimicking diet (FMD) is a promising type of dietary intervention that have beneficial effects in the prevention and treatment of various cancers. We investigated the therapeutic effect of 4-day FMD against colorectal cancer in mice through immune cell analysis, microbiota composition analysis and anti-PD-1 treatment. These FMD cycles effectively suppressed colorectal cancer growth, reduced cell proliferation and angiogenesis, increased tumor-infiltration lymphocytes especially CD8 + T cells. FMD stimulated protective gut microbiota, especially Lactobacillus . Supplementation of Lactobacillus johnsonii induced similar results as FMD intervention, which also suppressed tumor growth and increased CD45 + and CD8 + T cells. Additionally, FMD synthesizing with anti-PD-1 therapy effectively inhibited CRC progression. These findings suggest that Lactobacillus. johnsonii is necessary for the anticancer process of FMD in CRC. FMD through its effects on both gut microbiota and immune system, effectively suppressed colorectal cancer progression in mouse model.
biotechnology & applied microbiology,microbiology
What problem does this paper attempt to address?
This paper aims to investigate the effects of periodic fasting-mimicking diet (FMD) on the immune cell profile and gut microbiota composition in a mouse model of colorectal cancer, and to evaluate the synergistic effect of combining FMD with immunotherapy in enhancing the treatment efficacy of colorectal cancer. Specifically, the study found that FMD significantly inhibited the growth of colorectal cancer, reduced tumor volume and weight, and decreased the expression of Ki67 and CD31, which are usually associated with cancer cell proliferation and angiogenesis. Additionally, FMD altered the tumor immune microenvironment by increasing the number of CD8+ T cells in tumor cells and peripheral blood mononuclear cells (PBMCs), thereby enhancing the anti-tumor immune response. The study also showed that FMD could reshape the gut microbiota structure, particularly increasing the number of beneficial bacteria such as Lactobacillus, with Lactobacillus johnsonii exhibiting anti-cancer effects similar to FMD intervention. Finally, the study found that the combination of FMD and anti-PD-1 therapy more effectively inhibited the progression of colorectal cancer. These findings provide new strategies for improving the efficacy of colorectal cancer immunotherapy and the compliance of nutritional interventions.